数据驱动的剂量-体积直方图预测
本研究基于Oncospace放疗数据库,利用重叠体积直方图(OVH)查询相似器官的剂量-体积直方图(DVH),评估对临床实际DVH的预测能力。结果显示肺和体轮廓预测极佳,而食管和心脏预测较弱,提示非重叠器官的临床剂量可能受计划偏好和设计主导。
要点
- 肺和体轮廓的DVH预测极佳,IQR和NOR分别<4%和<16%(肺)、<1%和<5%(体)。
- 21/23例患者肺DVH-DB与DVH-CL差异<4.6%,14/23例差异<3%。
- 食管和心脏预测较弱,12/23例食管和10/23例心脏平均DVH差异>10%。
关键数值与推荐
- OVH(0cm)为OAR与PTV重叠的相对体积,OVH(2cm)为OAR距PTV 2cm处的相对体积。
- DVH数据分为四分位距(IQR)、非离群范围(NOR,等于3×IQR)及从NOR数据计算的平均数据库DVH(DVH-DB)。
- 肺和体轮廓在距PTV小于2cm的所有距离,IQR和NOR分别<4%和<16%(肺)、<1%和<5%(体)。
- 21/23例患者肺DVH-DB与DVH-CL差异<4.6%,14/23例差异<3%。
- 12/23例食管和10/23例心脏平均DVH差异>10%。
局限性
- 模型和数据驱动方法在基于有限数据集时存在局限性。
- 对于非重叠OAR,计划偏好和计划设计可能主导临床剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate dose-volume histogram (DVH) prediction from prior radiation therapy data. METHODS AND MATERIALS: An Oncospace radiation therapy database was constructed including images, structures, and dose distributions for patients with advanced lung cancer. DVH data was queried for total lungs, esophagus, heart, and external body contours. Each query returned DVH data for the N-most similar organs at risk (OARs) based on OAR-to-planning-target-volume (PTV) geometry via the overlap volume histogram (OVH). The DVHs for 5, 20, and 50 of the most similar OVHs were returned for each OAR for each patient. The OVH(0cm) is the relative volume of the OAR overlapping with the PTV, and the OVH(2cm) is the relative volume of the OAR 2 cm away from the PTV. The OVH(cm) and DVH(%) queried from the database were separated into interquartile ranges (IQRs), nonoutlier ranges (NORs) (equal to 3 × IQR), and the average database DVH (DVH-DB) computed from the NOR data. The ability to predict the clinically delivered DVH was evaluated based on percentiles and differences between the DVH-DB and the clinical DVH (DVH-CL) for a varying number of returned patient DVHs for a subset of patients. RESULTS: The ability to predict the clinically delivered DVH was excellent in the lungs and body; the IQR and NOR were <4% and <16%, respectively, in the lungs and <1% and <5%, respectively, in the body at all distances less than 2 cm from the PTV. For 21/23 patients considered, the differences in lung DVH-DB and DVH-CL were <4.6% and in 14/23 cases, <3%. In esophagus and heart, the ability to predict DVH-CL was weaker, with mean DVH differences >10% for 12/23 esophagi and 10/23 hearts. In esophagus and heart queries, the NOR was often 10% to 100% volume in dose ranges between 0% and 50% of prescription, independent of the number of patients queried. CONCLUSIONS: Using prior data to predict clinical dosimetry is increasingly of interest, but model- and data-driven methods have limitations if based on limited data sets. This study's results showed that prediction may be reasonable in organs containing tumors with known overlap, but for nonoverlapped OARs, planning preference and plan design may dominate the clinical dose.
引用
- Polizzi M, Watkins RW, Watkins WT, et al. Data-Driven Dose-Volume Histogram Prediction. Adv Radiat Oncol. 2021. PMID: 35079664. doi:10.1016/j.adro.2021.100841
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。